These findings, in addition to the wide and effective use of CD133 as a biomarker to isolate stem cells in cancerous tissues [18], [19], suggest that a subpopulation of CD133+ cells acts as CSCs in the metastasis of colon cancer. Here, PROM1 is linked to malignant colon neoplasm.